EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSFOG00015015424
Gene Symbol: DHCR24
1 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11a-Like

Ensembl ID : ENSSFOG00015000603
Gene Symbol: LOC108918626
3 Cross references
264 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 7-Like

Ensembl ID : ENSSFOG00015019662
Gene Symbol: LOC108926279
3 Cross references
222 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 8-Like

Ensembl ID : ENSSFOG00015023067
Gene Symbol: LOC108941456
3 Cross references
210 Possible Orthologues:

26s Proteasome Regulatory Subunit 7

Ensembl ID : ENSSFOG00015003388
Gene Symbol: LOC108931581
3 Cross references
231 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSSFOG00015016250
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSSFOG00015019160
Gene Symbol: PDPK1
3 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSSFOG00015004763
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSSFOG00015024890
Gene Symbol: LOC108939162
3 Cross references
379 Possible Orthologues:

40s Ribosomal Protein S15a

Ensembl ID : ENSSFOG00015032835
Gene Symbol: LOC108937152
3 Cross references
108 Possible Orthologues:

40s Ribosomal Protein S16

Ensembl ID : ENSSFOG00015019382
Gene Symbol: LOC108936435
3 Cross references
273 Possible Orthologues:

40s Ribosomal Protein S16-Like

Ensembl ID : ENSSFOG00015027301
Gene Symbol: LOC108942116
3 Cross references
267 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).